Sort
21,281 grants matching “influenza”
SAFETY AND IMMUNOGENICITY OF H3N2 M2SR MONOVALENT INFLUENZA VACCINE ADMINISTERED WITH INACTIVATED FLU VACCINE IN OLDER SUBJECTS
$11,439,843Flugen Inc · · FY2021 · Defense Health Agency
Vaccine and Treatment Evaluation Units
$11,432,119Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
Regulatory Support Services
$11,311,037Jerome Pierson · National Institute Of Allergy And Infectious Diseases · ZID · FY2017 · AI
Regulatory Support Services
$11,269,404Jerome Pierson · National Institute Of Allergy And Infectious Diseases · ZID · FY2019 · AI
COVID-19 Supplement #3 Moderna Trial
$11,154,495Daniel F. Hoft · Saint Louis University · UM1 · FY2020 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core
$11,116,941Thomas Denny · Duke University · N01 · FY2024 · AI
Regulatory Support Services
$11,085,480Laura McNay · National Institute Of Allergy And Infectious Diseases · ZID · FY2012 · AI
ARRA Anti-Viral and Immune Plasma Infrastructure Development
$11,040,026Social And Scientific Systems, Inc. · N01 · FY2009 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE
$10,890,088Matthew Johnson · Duke University · N01 · FY2023 · AI
Systems Approach to Immunity and Inflammation
$10,879,420Richard J Ulevitch · Scripps Research Institute, The · N01 · FY2011 · AI
EMIT: Evaluating Modes of Influenza Transmission using a Human Challenge Model
$10,849,395Jonathan Stafford Nguyen-Van-Tam · University Of Nottingham · U01 · FY2011 · IP
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$10,749,810Ted Ross · University Of Georgia · N01 · FY2020 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$10,700,042Ted Ross · University Of Georgia · N01 · FY2023 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
$10,693,906Tony Moody · Duke University · N01 · FY2023 · AI
Systems Approach to Immunity and Inflammation
$10,561,636Richard J Ulevitch · Scripps Research Institute, The · N01 · FY2010 · AI
Development/production of universal influenza vaccines
$10,496,412Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2019 · AI
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$10,482,503Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2012 · AI
RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM - PROJECT #6658
$10,295,000David Yoo · Genbody Inc. · N02 · FY2021 · HL
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$10,188,376Ted Ross · University Of Georgia · N01 · FY2022 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
$10,146,052Tony Moody · Duke University · N01 · FY2022 · AI
Human Respiratory Syncytial Virus Biology And Vaccine Development
$10,136,908Peter Leon Collins · Niaid Extramural Activities · Z01 · FY2007 · AI
Regulatory Support Services
$10,107,415Laura McNay · National Institute Of Allergy And Infectious Diseases · ZID · FY2014 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
$10,008,687Tony Moody · Duke University · N01 · FY2021 · AI
INTERAGENCY AGREEMENT BETWEEN THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES AND THE UNIFORMED SERVICES UNIVERSITY
$10,000,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER
$10,000,000Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI